Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORTHOCELL LIMITED Director's Dealing 2016

Mar 3, 2016

65477_rns_2016-03-03_23e6361e-09c5-4842-8cfd-861e8388e9ec.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Orthocell Limited
ABN 57 118 897 135

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Stewart Washer
Date of last notice 25/11/2014

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct and Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Dr Stewart James Washer & Dr Patrizia Derna
Washer <The Washer Family Superannuation
Fund
Dr Washer
is a
trustee and beneficiary of the
superannuation fund)
Mal Washer Nominees Pty Ltd Family A/C>
Dr Washer is a trustee and beneficiary of the trust)
Date of change 26/02/2016
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change
Stewart Washer
Dr Stewart James Washer & Dr Patrizia Derna
Washer <The Washer Family Superannuation
Fund
Mal Washer Nominees Pty Ltd Family A/C>
400,000 Unlisted Options exercisable at
$0.62 on or before 24 November 2017
204,267 Ordinary Shares
165,000 Ordinary Shares
1,250,000 Unlisted options exercisable
at $0.50 expiring 3 August 2017
Class Ordinary Shares
Unlisted Warrants
Number acquired 70,994 Ordinary Shares
95,842 Unlisted Warrants
Number disposed -
Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation
$35,000
No. of securities held after change
Stewart Washer
Dr Stewart James Washer & Dr Patrizia Derna
Washer <The Washer Family Superannuation
Fund
Dr Washer
is a
trustee and beneficiary of the
superannuation fund)
Mal Washer Nominees Pty Ltd Family A/C>
Dr Washer is a trustee and beneficiary of the trust)
400,000 Unlisted Options exercisable at
$0.62 on or before 24 November 2017
204,267 Ordinary Shares
235,994 Ordinary Shares
1,250,000 Unlisted options exercisable
at $0.50 expiring 3 August 2017
95,842 Unlisted Warrants exercisable at
$0.58 on or before 19 November 2020
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
Issue of securities as approved by
shareholders at a General Meeting on 27
January 2016

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
N/A
Interest after change N/A

Part 3 Closed Period

3 Closed Period
Were the interests in the securities or
contracts detailed above traded during a
+closed period where prior written
clearance was required?
No
If so, was prior written clearance
provided to allow the trade to proceed
during this period?
N/A
If prior written clearance was provided,
on what date was this provided?
N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 3